A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

NCT01641939 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Taxane
DRUG: trastuzumab emtansine
DRUG: trastuzumab emtansine

Sponsor

Hoffmann-La Roche